Tools
Upgrade to Pro 🌟

Upgrade for Pro stock ideas, Al signals, and more search.

Learn More

EMBC

Embecta Corporation · NASDAQ

Performance

-12.59%

1W

-0.22%

1M

-1.72%

3M

-3.76%

6M

-25.77%

YTD

-13.25%

1Y

Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Technical Analysis of EMBC 2024-11-20

The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 16 indicating strong downward pressure, the Oscillators Score at 46 suggesting a neutral stance, and the Technical Score at 31 reinforcing the bearish outlook. This combination points to a generally weak market sentiment, with potential challenges ahead fo...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of EMBC

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.